Splice variants of the P2X7 receptor reveal differential agonist dependence and functional coupling with pannexin-1

Journal of Cell Science

Volumn 125, Issue 16, 2012, Pages 3776-3789

  Xu, Xing Jian ^a   Boumechache, Miyyada ^a   Robinson, Lucy E ^a   Marschall, Viola ^a   Gorecki, Dariusz C ^b   Masin, Marianela ^a   Murrell Lagnado, Ruth D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

NAD; P2X7; Pannexin

Indexed keywords

ETHIDIUM; MEMBRANE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PANNEXIN 1; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2X7A RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM CELL LEVEL; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ADENOSINE DIPHOSPHATE; ANIMALS; CELL DEATH; CELL LINE; CONNEXINS; ETHIDIUM; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NAD; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; PURINERGIC P2X RECEPTOR AGONISTS; RECEPTORS, PURINERGIC P2X7; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFECTION;

EID: 84867112397     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.099374     Document Type: Article

References (64)

1. Adinolfi, E., Callegari, M. G., Ferrari, D., Bolognesi, C., Minelli, M., Wieckowski, M. R., Pinton, P., Rizzuto, R. and Di Virgilio, F. (2005). Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol. Biol. Cell 16, 3260-3272.
2. Adinolfi, E., Cirillo, M., Woltersdorf, R., Falzoni, S., Chiozzi, P., Pellegatti, P., Callegari, M. G., Sandonà, D., Markwardt, F., Schmalzing, G. et al. (2010). Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J. 24, 3393-3404.
3. Adriouch, S., Dox, C., Welge, V., Seman, M., Koch-Nolte, F. and Haag, F. (2002). Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J. Immunol. 169, 4108-4112.
4. Adriouch, S., Bannas, P., Schwarz, N., Fliegert, R., Guse, A. H., Seman, M., Haag, F. and Koch-Nolte, F. (2008). ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site. FASEB J. 22, 861-869.
5. Antonio, L. S., Stewart, A. P., Xu, X. J., Varanda, W. A., Murrell-Lagnado, R. D. and Edwardson, J. M. (2011). P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers. Br. J. Pharmacol. 163, 1069-1077.
6. Bao, L., Locovei, S. and Dahl, G. (2004). Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett. 572, 65-68.
7. Baranova, A., Ivanov, D., Petrash, N., Pestova, A., Skoblov, M., Kelmanson, I., Shagin, D., Nazarenko, S., Geraymovych, E., Litvin, O. et al. (2004). The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics 83, 706-716.
8. Boumechache, M., Masin, M., Edwardson, J. M., Górecki, D. C. and Murrell- Lagnado, R. (2009). Analysis of assembly and trafficking of native P2X4 and P2X7 receptor complexes in rodent immune cells. J. Biol. Chem. 284, 13446-13454.
9. Brough, D., Le Feuvre, R. A., Iwakura, Y. and Rothwell, N. J. (2002). Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1- independent mechanism. Mol. Cell. Neurosci. 19, 272-280.
10. Cabrini, G., Falzoni, S., Forchap, S. L., Pellegatti, P., Balboni, A., Agostini, P., Cuneo, A., Castoldi, G., Baricordi, O. R. and Di Virgilio, F. (2005). A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J. Immunol. 175, 82-89.
11. Cankurtaran-Sayar, S., Sayar, K. and Ugur, M. (2009). P2X7 receptor activates multiple selective dye-permeation pathways in RAW 264.7 and human embryonic kidney 293 cells. Mol. Pharmacol. 76, 1323-1332.
12. Cheewatrakoolpong, B., Gilchrest, H., Anthes, J. C. and Greenfeder, S. (2005). Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem. Biophys. Res. Commun. 332, 17-27.
13. Chekeni, F. B., Elliott, M. R., Sandilos, J. K., Walk, S. F., Kinchen, J. M., Lazarowski, E. R., Armstrong, A. J., Penuela, S., Laird, D. W., Salvesen, G. S. et al. (2010). Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 467, 863-867.
14. Chen, L. and Brosnan, C. F. (2006). Regulation of immune response by P2X7 receptor. Crit. Rev. Immunol. 26, 499-513.
15. Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J., Peck, W. L. et al. (2005). Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114, 386-396.
16. Dardano, A., Falzoni, S., Caraccio, N., Polini, A., Tognini, S., Solini, A., Berti, P., Di Virgilio, F. and Monzani, F. (2009). 1513A.C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters. J. Clin. Endocrinol. Metab. 94, 695-698.
17. Denlinger, L. C., Fisette, P. L., Sommer, J. A., Watters, J. J., Prabhu, U., Dubyak, G. R., Proctor, R. A. and Bertics, P. J. (2001). Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J. Immunol. 167, 1871-1876.
18. Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G. and Baricordi, O. R. (2001). Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97, 587-600.
19. Donnelly-Roberts, D. L. and Jarvis, M. F. (2007). Discovery of P2X7 receptor- selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br. J. Pharmacol. 151, 571-579.
20. Eickhorst, A. N., Berson, A., Cockayne, D., Lester, H. A. and Khakh, B. S. (2002). Control of P2X(2) channel permeability by the cytosolic domain. J. Gen. Physiol. 120, 119-131.
21. Faria, R. X., Defarias, F. P. and Alves, L. A. (2005). Are second messengers crucial for opening the pore associated with P2X7 receptor? Am. J. Physiol. Cell Physiol. 288, C260-C271.
22. Feng, Y. H., Li, X., Wang, L., Zhou, L. and Gorodeski, G. I. (2006a). A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J. Biol. Chem. 281, 17228-17237.
23. Feng, Y. H., Li, X., Zeng, R. and Gorodeski, G. I. (2006b). Endogenously expressed truncated P2X7 receptor lacking the C-terminus is preferentially upregulated in epithelial cancer cells and fails to mediate ligand-induced pore formation and apoptosis. Nucleosides Nucleotides Nucleic Acids 25, 1271-1276.
24. Gu, B. J., Zhang, W., Worthington, R. A., Sluyter, R., Dao-Ung, P., Petrou, S., Barden, J. A. and Wiley, J. S. (2001). A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J. Biol. Chem. 276, 11135-11142.
25. Gu, B. J., Rathsam, C., Stokes, L., McGeachie, A. B. and Wiley, J. S. (2009). Extracellular ATP dissociates nonmuscle myosin from P2X(7) complex: this dissociation regulates P2X(7) pore formation. Am. J. Physiol. Cell Physiol. 297, C430-C439.
26. Guerra, A. N., Fisette, P. L., Pfeiffer, Z. A., Quinchia-Rios, B. H., Prabhu, U., Aga, M., Denlinger, L. C., Guadarrama, A. G., Abozeid, S., Sommer, J. A. et al. (2003). Purinergic receptor regulation of LPS-induced signaling and pathophysiology. J. Endotoxin Res. 9, 256-263.
27. Guo, C., Masin, M., Qureshi, O. S. and Murrell-Lagnado, R. D. (2007). Evidence for functional P2X4/P2X7 heteromeric receptors. Mol. Pharmacol. 72, 1447-1456.
28. Hong, S., Schwarz, N., Brass, A., Seman, M., Haag, F., Koch-Nolte, F., Schilling, W. P. and Dubyak, G. R. (2009). Differential regulation of P2X7 receptor activation by extracellular nicotinamide adenine dinucleotide and ecto-ADP-ribosyltransferases in murine macrophages and T cells. J. Immunol. 183, 578-592.
29. Iglesias, R., Locovei, S., Roque, A., Alberto, A. P., Dahl, G., Spray, D. C. and Scemes, E. (2008). P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am. J. Physiol. Cell Physiol. 295, C752-C760.
30. Jiang, L. H., Rassendren, F., Mackenzie, A., Zhang, Y. H., Surprenant, A. and North, R. A. (2005). N-methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X(7) receptors. Am. J. Physiol. Cell Physiol. 289, C1295-C1302.
31. Khakh, B. S., Bao, X. R., Labarca, C. and Lester, H. A. (1999). Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nat. Neurosci. 2, 322-330.
32. Kim, M., Jiang, L. H., Wilson, H. L., North, R. A. and Surprenant, A. (2001). Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 20, 6347-6358.
33. Le Stunff, H., Auger, R., Kanellopoulos, J. and Raymond, M.-N. (2004). The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J. Biol. Chem. 279, 16918-16926.
34. Locovei, S., Bao, L. and Dahl, G. (2006). Pannexin 1 in erythrocytes: function without a gap. Proc. Natl. Acad. Sci. USA 103, 7655-7659.
35. Locovei, S., Scemes, E., Qiu, F., Spray, D. C. and Dahl, G. (2007). Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett. 581, 483-488.
36. Ma, W., Hui, H., Pelegrin, P. and Surprenant, A. (2009). Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J. Pharmacol. Exp. Ther. 328, 409-418.
37. Mackenzie, A. B., Young, M. T., Adinolfi, E. and Surprenant, A. (2005). Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J. Biol. Chem. 280, 33968-33976.
38. Masin, M., Young, C., Lim, K., Barnes, S. J., Xu, X. J., Marschall, V., Brutkowski, W., Mooney, E. R., Gorecki, D. C. and Murrell-Lagnado, R. (2012). Expression, assembly and function of novel C-terminal truncated variants of the mouse P2X7 receptor: re-evaluation of P2X7 knockouts. Br. J. Pharmacol. 165, 978-993.
39. Moore, S. F. and MacKenzie, A. B. (2007). Murine macrophage P2X7 receptors support rapid prothrombotic responses. Cell. Signal. 19, 855-866.
40. Nicke, A., Kuan, Y. H., Masin, M., Rettinger, J., Marquez-Klaka, B., Bender, O., Górecki, D. C., Murrell-Lagnado, R. D. and Soto, F. (2009). A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J. Biol. Chem. 284, 25813-25822.
41. North, R. A. (2002). Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013-1067.
42. Nuttle, L. C. and Dubyak, G. R. (1994). Differential activation of cation channels and non-selective pores by macrophage P2z purinergic receptors expressed in Xenopus oocytes. J. Biol. Chem. 269, 13988-13996.
43. Okkenhaug, K., Patton, D. T., Bilancio, A., Garçon, F., Rowan, W. C. and Vanhaesebroeck, B. (2006). The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J. Immunol. 177, 5122-5128.
44. Pelegrin, P. and Surprenant, A. (2006). Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25, 5071-5082.
45. Pelegrin, P. and Surprenant, A. (2009). The P2X(7) receptor-pannexin connection to dye uptake and IL-1beta release. Purinergic Signal. 5, 129-137.
46. Pfeiffer, Z. A., Aga, M., Prabhu, U., Watters, J. J., Hall, D. J. and Bertics, P. J. (2004). The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J. Leukoc. Biol. 75, 1173-1182.
47. Placido, R., Auricchio, G., Falzoni, S., Battistini, L., Colizzi, V., Brunetti, E., Di Virgilio, F. and Mancino, G. (2006). P2X(7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. Cell. Immunol. 244, 10-18.
48. Qiu, F. and Dahl, G. (2009). A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. Am. J. Physiol. Cell Physiol. 296, C250-C255.
49. Qu, Y., Misaghi, S., Newton, K., Gilmour, L. L., Louie, S., Cupp, J. E., Dubyak, G. R., Hackos, D. and Dixit, V. M. (2011). Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J. Immunol. 186, 6553-6561.
50. Qureshi, O. S., Paramasivam, A., Yu, J. C. and Murrell-Lagnado, R. D. (2007). Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J. Cell Sci. 120, 3838-3849.
51. Ransford, G. A., Fregien, N., Qiu, F., Dahl, G., Conner, G. E. and Salathe, M. (2009). Pannexin 1 contributes to ATP release in airway epithelia. Am. J. Respir. Cell Mol. Biol. 41, 525-534.
52. Scemes, E., Spray, D. C. and Meda, P. (2009). Connexins, pannexins, innexins: novel roles of "hemi-channels". Pflugers Arch. 457, 1207-1226.
53. Schachter, J., Motta, A. P., de Souza Zamorano, A., da Silva-Souza, H. A., Guimarães, M. Z. and Persechini, P. M. (2008). ATP-induced P2X7-associated uptake of large molecules involves distinct mechanisms for cations and anions in macrophages. J. Cell Sci. 121, 3261-3270.
54. Seman, M., Adriouch, S., Scheuplein, F., Krebs, C., Freese, D., Glowacki, G., Deterre, P., Haag, F. and Koch-Nolte, F. (2003). NAD-induced T cell death: ADP- ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19, 571-582.
55. Sikora, A., Liu, J., Brosnan, C., Buell, G., Chessel, I. and Bloom, B. R. (1999). Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism. J. Immunol. 163, 558-561.
56. Smart, M. L., Gu, B., Panchal, R. G., Wiley, J., Cromer, B., Williams, D. A. and Petrou, S. (2003). P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J. Biol. Chem. 278, 8853-8860.
57. Taylor, S. R., Gonzalez-Begne, M., Dewhurst, S., Chimini, G., Higgins, C. F., Melvin, J. E. and Elliott, J. I. (2008). Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J. Immunol. 180, 300-308.
58. Taylor, S. R., Gonzalez-Begne, M., Sojka, D. K., Richardson, J. C., Sheardown, S. A., Harrison, S. M., Pusey, C. D., Tam, F. W. and Elliott, J. I. (2009). Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses. J. Leukoc. Biol. 85, 978-986.
59. Verhoef, P. A., Estacion, M., Schilling, W. and Dubyak, G. R. (2003). P2X7 receptor- dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. J. Immunol. 170, 5728-5738.
60. Virginio, C., MacKenzie, A., North, R. A. and Surprenant, A. (1999). Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J. Physiol. 519, 335-346.
61. Wiley, J. S., Dao-Ung, L. P., Gu, B. J., Sluyter, R., Shemon, A. N., Li, C., Taper, J., Gallo, J. and Manoharan, A. (2002). A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 359, 1114-1119.
62. Wilson, H. L., Wilson, S. A., Surprenant, A. and North, R. A. (2002). Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J. Biol. Chem. 277, 34017-34023.
63. Yan, Z., Li, S., Liang, Z., Tomić, M. and Stojilkovic, S. S. (2008). The P2X7 receptor channel pore dilates under physiological ion conditions. J. Gen. Physiol. 132, 563-573.
64. Yip, L., Woehrle, T., Corriden, R., Hirsh, M., Chen, Y., Inoue, Y., Ferrari, V., Insel, P. A. and Junger, W. G. (2009). Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J. 23, 1685-1693.